Cargando…
The Impact of Proton Pump Inhibitors on the Development of Gastric Neoplastic Lesions in Patients With Autoimmune Atrophic Gastritis
INTRODUCTION: Proton pump inhibitors (PPIs) have been widely prescribed as a primary treatment for acid-related disorders. A large body of literature reported several adverse outcomes due to PPI therapy, including an increased risk of gastric cancer (GC). Autoimmune atrophic gastritis (AAG) is a chr...
Autores principales: | Dilaghi, Emanuele, Bellisario, Mario, Esposito, Gianluca, Carabotti, Marilia, Annibale, Bruno, Lahner, Edith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353125/ https://www.ncbi.nlm.nih.gov/pubmed/35935934 http://dx.doi.org/10.3389/fimmu.2022.910077 |
Ejemplares similares
-
Treatment of Helicobacter pylori infection in atrophic gastritis
por: Lahner, Edith, et al.
Publicado: (2018) -
Gastric Microbiota Gender Differences in Subjects with Healthy Stomachs and Autoimmune Atrophic Gastritis
por: Pivetta, Giulia, et al.
Publicado: (2023) -
Medical care of atrophic gastritis patients during COVID-19 pandemic: Results of telemedicine in a referral center
por: Esposito, Gianluca, et al.
Publicado: (2020) -
Upper gastrointestinal symptoms in autoimmune gastritis: A cross-sectional study
por: Carabotti, Marilia, et al.
Publicado: (2017) -
Luminescent Immunoprecipitation System (LIPS) for Detection of Autoantibodies Against ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase in Atrophic Body Gastritis Patients
por: Lahner, Edith, et al.
Publicado: (2017)